The multicenter Baby HUG trial led by St. Jude Children’s Research Hospital investigators shows hydroxyurea reduces the most common symptoms of sickle cell anemia in children, raising hopes the drug will ease complications and improve patient quality of life.
Read More...
[Source: St. Jude Children's Research Hospital - Latest News]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment